Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 7 studies | 23% ± 8% | |
retinal rod cell | 6 studies | 28% ± 4% | |
kidney loop of Henle epithelial cell | 5 studies | 22% ± 4% | |
retinal cone cell | 5 studies | 32% ± 6% | |
cardiac muscle cell | 4 studies | 18% ± 2% | |
retinal bipolar neuron | 3 studies | 24% ± 5% | |
rod bipolar cell | 3 studies | 23% ± 3% | |
glutamatergic neuron | 3 studies | 25% ± 11% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
eye | 6 studies | 23% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 97% | 2065.09 | 2556 / 2642 | 100% | 30.67 | 702 / 705 |
kidney | 97% | 2961.53 | 86 / 89 | 95% | 21.83 | 856 / 901 |
adrenal gland | 97% | 1551.67 | 251 / 258 | 47% | 5.38 | 108 / 230 |
pancreas | 74% | 546.55 | 244 / 328 | 63% | 4.04 | 112 / 178 |
skin | 67% | 1118.90 | 1217 / 1809 | 63% | 3.93 | 298 / 472 |
esophagus | 80% | 958.07 | 1155 / 1445 | 50% | 2.67 | 91 / 183 |
uterus | 74% | 771.99 | 126 / 170 | 53% | 3.78 | 241 / 459 |
thymus | 51% | 392.67 | 334 / 653 | 74% | 4.16 | 445 / 605 |
liver | 49% | 465.94 | 110 / 226 | 75% | 5.54 | 303 / 406 |
ovary | 50% | 678.88 | 90 / 180 | 69% | 3.72 | 298 / 430 |
breast | 52% | 431.50 | 238 / 459 | 50% | 2.34 | 563 / 1118 |
muscle | 100% | 9996.39 | 803 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 4539.45 | 844 / 861 | 0% | 0 | 0 / 0 |
intestine | 62% | 864.60 | 599 / 966 | 32% | 1.58 | 171 / 527 |
bladder | 62% | 514.76 | 13 / 21 | 30% | 1.41 | 149 / 504 |
stomach | 48% | 548.72 | 171 / 359 | 36% | 1.75 | 103 / 286 |
lung | 33% | 276.68 | 190 / 578 | 46% | 2.26 | 535 / 1155 |
eye | 0% | 0 | 0 / 0 | 75% | 4.10 | 60 / 80 |
adipose | 61% | 636.34 | 740 / 1204 | 0% | 0 | 0 / 0 |
prostate | 37% | 411.37 | 91 / 245 | 21% | 0.90 | 107 / 502 |
blood vessel | 51% | 807.66 | 678 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 38% | 8.34 | 11 / 29 |
tonsil | 0% | 0 | 0 / 0 | 24% | 1.70 | 11 / 45 |
peripheral blood | 1% | 5.44 | 8 / 929 | 0% | 0 | 0 / 0 |
spleen | 1% | 4.52 | 2 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045475 | Biological process | locomotor rhythm |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0045931 | Biological process | positive regulation of mitotic cell cycle |
GO_0050821 | Biological process | protein stabilization |
GO_0006508 | Biological process | proteolysis |
GO_1901796 | Biological process | regulation of signal transduction by p53 class mediator |
GO_0007517 | Biological process | muscle organ development |
GO_0016579 | Biological process | protein deubiquitination |
GO_0043153 | Biological process | entrainment of circadian clock by photoperiod |
GO_0048512 | Biological process | circadian behavior |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016020 | Cellular component | membrane |
GO_0005813 | Cellular component | centrosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0004843 | Molecular function | cysteine-type deubiquitinase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0004197 | Molecular function | cysteine-type endopeptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0030332 | Molecular function | cyclin binding |
Gene name | USP2 |
Protein name | Ubiquitin carboxyl-terminal hydrolase 2 (EC 3.4.19.12) (41 kDa ubiquitin-specific protease) (Deubiquitinating enzyme 2) (Ubiquitin thioesterase 2) (Ubiquitin-specific-processing protease 2) Ubiquitin specific peptidase 2 |
Synonyms | UBP41 |
Description | FUNCTION: Hydrolase that deubiquitinates polyubiquitinated target proteins such as MDM2, MDM4 and CCND1 . Isoform 1 and isoform 4 possess both ubiquitin-specific peptidase and isopeptidase activities (By similarity). Deubiquitinates MDM2 without reversing MDM2-mediated p53/TP53 ubiquitination and thus indirectly promotes p53/TP53 degradation and limits p53 activity . Has no deubiquitinase activity against p53/TP53 . Prevents MDM2-mediated degradation of MDM4 . Plays a role in the G1/S cell-cycle progression in normal and cancer cells . Regulates the circadian clock by modulating its intrinsic circadian rhythm and its capacity to respond to external cues (By similarity). Associates with clock proteins and deubiquitinates core clock component PER1 but does not affect its overall stability (By similarity). Regulates the nucleocytoplasmic shuttling and nuclear retention of PER1 and its repressive role on the clock transcription factors CLOCK and BMAL1 (By similarity). Plays a role in the regulation of myogenic differentiation of embryonic muscle cells (By similarity). .; FUNCTION: [Isoform 4]: Circadian clock output effector that regulates Ca(2+) absorption in the small intestine. Probably functions by regulating protein levels of the membrane scaffold protein NHERF4 in a rhythmic manner, and is therefore likely to control Ca(2+) membrane permeability mediated by the Ca(2+) channel TRPV6 in the intestine. . |
Accessions | E9PSH6 ENST00000525735.1 [O75604-4] ENST00000531070.1 ENST00000260187.7 [O75604-1] ENST00000527843.1 E9PJ34 O75604 ENST00000455332.6 [O75604-3] |